Hypercalcemia and elevated calcitriol in a maintenance dialysis patient with tuberculosis.
暂无分享,去创建一个
[1] E. Hendler,et al. Hypercalcemia and elevated 1,25-dihydroxyvitamin D levels in a patient with end-stage renal disease and active tuberculosis. , 1984, The New England journal of medicine.
[2] H. Harter,et al. Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients. , 1984, The Journal of clinical investigation.
[3] A. Barbato,et al. Hypercalcemia associated with silicone-induced granulomas. , 1984, The New England journal of medicine.
[4] T. Yasuda,et al. 1,25-Dihydroxyvitamin D production after stimulation with synthetic human parathyroid hormone (1-34) in hypoparathyroid and renal tubular disorders. , 1984, Endocrinologia japonica.
[5] T. Clemens,et al. Studies of the hypercalcaemia of sarcoidosis: effect of steroids and exogenous vitamin D3 on the circulating concentrations of 1,25-dihydroxy vitamin D3. , 1984, The Quarterly journal of medicine.
[6] D. Andress,et al. Parathyroid hormone and bone histology: response to hypocalcemia in osteitis fibrosa. , 1984, Kidney international.
[7] M. S. Parker,et al. Hypercalcemia in coccidioidomycosis. , 1984, The American journal of medicine.
[8] S. Adami,et al. Suppression of secondary hyperparathyroidism in uraemia: acute and chronic studies. , 1984, British medical journal.
[9] D. Andress,et al. Parathyroid hormone response to hypocalcemia in hemodialysis patients with osteomalacia. , 1983, Kidney international.
[10] U. Binswanger,et al. Rapidity of plasma 1,25-dihydroxyvitamin D responses to hypo- and hypercalcemia in steers. , 1983, Endocrinology.
[11] M. Holick,et al. Normocalcemia in a hypoparathyroid patient with sarcoidosis: evidence for parathyroid-hormone-independent synthesis of 1,25 dihydroxyvitamin D. , 1983, Annals of internal medicine.
[12] J. Eisman,et al. A TEST OF 1,25‐DIHYDROXYVITAMIN D3 SECRETORY CAPACITY IN NORMAL SUBJECTS FOR APPLICATION IN METABOLIC BONE DISEASES , 1983, Clinical endocrinology.
[13] H. DeLuca,et al. 1,25-dihydroxyvitamin D3-treated hypoparathyroidism: 35 patients years in 10 children. , 1982, The Journal of clinical endocrinology and metabolism.
[14] A. Norman,et al. Hypercalcemia in an anephric patient with sarcoidosis: evidence for extrarenal generation of 1,25-dihydroxyvitamin D. , 1981, The New England journal of medicine.
[15] M. Haussler,et al. The pathophysiology of altered calcium metabolism in rhabdomyolysis-induced acute renal failure. Interactions of parathyroid hormone, 25-hydroxycholecalciferol, and 1,25-dihydroxycholecalciferol. , 1981, The New England journal of medicine.
[16] G. Lester,et al. Vitamin D and pregnancy: the maternal-fetal metabolism of vitamin D. , 1981, Endocrine reviews.
[17] N. Bell,et al. Evidence for abnormal regulation of circulating 1 alpha,25-dihydroxyvitamin D in patients with sarcoidosis and normal calcium metabolism. , 1980, The Journal of clinical investigation.
[18] J. Eisman,et al. Calcium-dependent, parathyroid hormone-independent regulation of 1,25-dihydroxyvitamin D. , 1980, The American journal of physiology.
[19] M. Friedberg,et al. Serum 1,25-DihydroxycholecalciferoI in Anephric, Haemodialyzed and Kidneytransplanted Patients , 1980 .
[20] A. Norman,et al. Stimulation of 1,25-dihydroxyvitamin D production by parathyroid hormone and hypocalcemia in man. , 1980, The Journal of clinical endocrinology and metabolism.
[21] J. Eisman,et al. MODULATION OF PLASMA 1,25-DIHYDROXYVITAMIN D IN MAN BY STIMULATION AND SUPPRESSION TESTS , 1979, The Lancet.
[22] J. Lemann,et al. The effects of oral CaCO3 loading and dietary calcium deprivation on plasma 1,25-dihydroxyvitamin D concentrations in healthy adults. , 1979, The Journal of clinical endocrinology and metabolism.
[23] S. Farah,et al. Hypercalcemia in active pulmonary tuberculosis. , 1979, Annals of internal medicine.
[24] H. DeLuca,et al. Response of 1alpha,25-dihydroxyvitamin D3 to hypocalcemia in human subjects. , 1978, The New England journal of medicine.
[25] J. G. Hurst,et al. Sigmoidal relationship between parathyroid hormone secretion rate and plasma calcium concentration in calves. , 1978, Endocrinology.
[26] J. C. Lee,et al. Hypercalcemia in disseminated coccidioidomycosis. , 1977, The New England journal of medicine.
[27] H. DeLuca,et al. Determination of 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 in human plasma using high-pressure liquid chromatography. , 1977, Analytical biochemistry.
[28] R. Freeman,et al. Histoplasmosis with hypercalcemia, renal failure, and papillary necrosis. Confusion with sarcoidosis.. , 1977, JAMA.
[29] H. DeLuca,et al. A sensitive, precise, and convenient method for determination of 1,25-dihydroxyvitamin D in human plasma. , 1976, Archives of biochemistry and biophysics.
[30] J. Habener,et al. Parathyroid hormone secretion in vivo. Demonstration of a calcium-independent nonsuppressible component of secretion. , 1976, The Journal of clinical investigation.
[31] M. Haussler,et al. THE ASSAY OF 1α, 25‐DIHYDROXYVITAMIN D3: PHYSIOLOGIC AND PATHOLOGIC MODULATION OF CIRCULATING HORMONE LEVELS , 1976, Clinical endocrinology.
[32] J. Wergedal,et al. Regulation of serum 1alpha,25-dihydroxyvitamin D3 by calcium and phosphate in the rat , 1975, Science.
[33] J. Wergedal,et al. Decrease in serum immunoreactive parathyroid hormone in rats and in parathyroid hormone secretion in vitro by 1,25-dihydroxycholecalciferol. , 1975, The Journal of clinical investigation.
[34] U. Binswanger,et al. Acute parathyroid hormone response: sensitivity, relationship to hypocalcemia, and rapidity. , 1974, Endocrinology.
[35] S. Massry,et al. 1,25 Dihydroxy-vitamin D3 in normal man and patients with renal failure. , 1974, Annals of internal medicine.
[36] S. Braman,et al. Steroid-responsive hypercalcemia in disseminated bone tuberculosis. , 1973, Archives of internal medicine.
[37] D. Fraser,et al. Regulation of 25-hydroxycholecalciferol-1-hydroxylase activity in kidney by parathyroid hormone. , 1973, Nature: New biology.
[38] S. Wallach,et al. Hypercalcemia in mycobacterial infection. , 1972, The Journal of clinical endocrinology and metabolism.
[39] H. DeLuca,et al. Vitamin D Metabolism: The Role of Kidney Tissue , 1971, Science.
[40] D. Fraser,et al. Unique Biosynthesis by Kidney of a Biologically Active Vitamin D Metabolite , 1970, Nature.
[41] J. Stoeckle,et al. Chronic beryllium disease. Long-term follow-up of sixty cases and selective review of the literature. , 1969, The American journal of medicine.
[42] O. Bergeim,et al. CALCIUM IN THE BLOOD IN TUBERCULOSIS , 1917 .
[43] E. Frenkel,et al. Hypercalcemia associated with increased serum calcitriol levels in three patients with lymphoma. , 1984, Annals of internal medicine.
[44] V. Batuman,et al. Elevated 1,25-dihydroxyvitamin D levels: occurrence with sarcoidosis with end-stage renal disease. , 1982, Archives of internal medicine.